Enpro CFO granted 3,147 stock options

Enpro Inc. executive vice president and CFO Joseph F. Bruderek Jr. received a grant of 3,147 stock options.

Accepted by SEC EDGAR 02/24/2026 - 05:33 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Enpro Inc. executive vice president and CFO Joseph F. Bruderek Jr. received a grant of 3,147 stock options. The options carry an exercise price of $0.00 and will vest in approximately equal thirds on February 23 of 2027, 2028 and 2029, subject to continued employment.

Insider Trade Summary

Grant/Award: 3,147 shares

Grant/Award 1 txn

Insider Bruderek Joseph F Jr.

Role EVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	3,147	$0.00	$0.00

Holdings After Transaction: Stock Option — 3,147 contracts (Direct)

Footnotes (1)

1. F1. The stock options will vest, subject to continued employment, in approximate equal thirds on 2/23/2027, 2/23/2028 and 2/23/2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Enpro Inc. (NPO) report for Joseph F. Bruderek Jr.?

Enpro Inc. reported that EVP and CFO Joseph F. Bruderek Jr. received a grant of 3,147 stock options. These options were awarded at an exercise price of $0.00 and represent a form of equity-based compensation tied to his continued service with the company.

How many Enpro Inc. (NPO) stock options were granted to the EVP and CFO?

Joseph F. Bruderek Jr., Enpro’s EVP and CFO, was granted 3,147 stock options. This award increases his derivative holdings by the same amount and aligns his compensation with Enpro’s long-term performance through equity incentives rather than immediate cash payments.

What is the vesting schedule for the Enpro Inc. (NPO) stock options granted?

The 3,147 stock options granted to Enpro’s EVP and CFO vest in three approximately equal installments. Vesting occurs on February 23, 2027, February 23, 2028 and February 23, 2029, and is conditioned on his continued employment with Enpro through those dates.

What is the exercise price of the new Enpro Inc. (NPO) stock options?

The newly granted 3,147 stock options for Enpro’s EVP and CFO carry an exercise price of $0.00 per share. This value reflects the accounting grant terms disclosed and indicates no cash outlay is required from the executive to receive the underlying shares at exercise.

Is the Enpro Inc. (NPO) insider stock option grant a buy or sell transaction?

The Enpro Inc. transaction is categorized as an acquisition via grant or award, not an open-market buy or sell. It reflects equity compensation awarded to the EVP and CFO, increasing his derivative holdings without a corresponding purchase or sale on the public market.

Who received the reported Enpro Inc. (NPO) stock option grant and in what capacity?

The recipient is Joseph F. Bruderek Jr., serving as executive vice president and chief financial officer of Enpro Inc. The grant of 3,147 stock options is held directly in his name and represents part of his executive incentive compensation package tied to future service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bruderek Joseph F Jr.

(Last) (First) (Middle)

5605 CARNEGIE BLVD.

SUITE 500

(Street)

CHARLOTTE NC 28209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enpro Inc. [ NPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$275.37	02/23/2026		A		3,147		(1)	02/23/2036	Common Stock	3,147	$0.0000	3,147	D

Explanation of Responses:

1. The stock options will vest, subject to continued employment, in approximate equal thirds on 2/23/2027, 2/23/2028 and 2/23/2029.

	Angela P. Winter, attorney-in-fact of Joseph F. Bruderek Jr.	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.